Literature DB >> 2887431

Effects of single oral doses of clobazam, diazepam and lorazepam on performance tasks and memory.

A Patat, M J Klein, M Hucher.   

Abstract

The effects on memory and psychomotor performance and the subjective effects of three anxiolytic benzodiazepines (lorazepam 2 mg, diazepam 10 mg and clobazam 20 mg p.o.) have been evaluated in a double-blind, placebo-controlled, cross-over study in 10 healthy volunteers. At each session, measurements were made prior to and +3.5 h after drug administration, except in the case of REY's test, which was presented at H + 1 h (learning) and was evaluated at H + 8 h and at H + 24 h (delayed recall). Single clinical doses of diazepam and lorazepam caused anterograde amnesia by disturbing acquisition, consolidation and retrieval. Clobazam did not impair memory. Lorazepam impaired performances in all the tests used to evaluate perception, immediate memory, reaction time, psychomotor skill and intellectual capacity. Diazepam caused a decrease in cortical arousal and the speed of perception of visual stimuli, whereas clobazam increased reaction time and reduced cortical arousal. Lorazepam caused a significant degradation of performance relative to the other two treatments.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887431     DOI: 10.1007/bf00637670

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam.

Authors:  K Seppälä; K Korttila; S Häkkinen; M Linnoila
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Effect on postural sway of various benzodiazepine tranquillizers.

Authors:  A Patat; P Foulhoux
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

3.  Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: relationship to plasma concentrations.

Authors:  N Pomara; B Stanley; R Block; J Guido; D Russ; R Berchou; M Stanley; D J Greenblatt; R E Newton; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 4.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

5.  Lorazepam on visuo-motor co-ordination and visual function in man.

Authors:  R W Bell; D S Dickie; J Stewart-Jones; P Turner
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

6.  Relative amnesic actions of diazepam, flunitrazepam and lorazepam in man.

Authors:  K A George; J W Dundee
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

7.  Effects of alcohol on buspirone and lorazepam actions.

Authors:  T Seppälä; K Aranko; M J Mattila; R C Shrotriya
Journal:  Clin Pharmacol Ther       Date:  1982-08       Impact factor: 6.875

8.  Impaired performance and sedation after a single dose of lorazepam.

Authors:  S E File; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

9.  Memory and performance effects of single and 3-week administration of diazepam.

Authors:  M M Ghoneim; S P Mewaldt; J L Berie; J V Hinrichs
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Sedative-hypnotics and human performance.

Authors:  L C Johnson; D A Chernik
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  7 in total

Review 1.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 2.  Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors:  Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal:  Ther Drug Monit       Date:  2013-02       Impact factor: 3.681

3.  Effects of loprazolam on cognitive functions.

Authors:  S R Bareggi; L Ferini-Strambi; R Pirola; M Franceschi; S Smirne
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Effects of flunitrazepam on cognitive functions.

Authors:  S Smirne; L Ferini-Strambi; R Pirola; O Tancredi; M Franceschi; P Pinto; S R Bareggi
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls.

Authors:  T Sunderland; H Weingartner; R M Cohen; P N Tariot; P A Newhouse; K E Thompson; B A Lawlor; E A Mueller
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Effects of clobazam and clonazepam on saccadic eye movements and other parameters of psychomotor performance.

Authors:  C H van der Meyden; P R Bartel; D K Sommers; M Blom; L C Pretorius
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Dose-dependent effects of intravenous lorazepam on cardiovascular activity, plasma catecholamines and psychological function during rest and mental stress.

Authors:  J H Tulen; P Moleman; F Boomsma; H G van Steenis; V J van den Heuij
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.